These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25332143)

  • 1. MTA family of proteins in prostate cancer: biology, significance, and therapeutic opportunities.
    Levenson AS; Kumar A; Zhang X
    Cancer Metastasis Rev; 2014 Dec; 33(4):929-42. PubMed ID: 25332143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer.
    Dhar S; Kumar A; Zhang L; Rimando AM; Lage JM; Lewin JR; Atfi A; Zhang X; Levenson AS
    Oncotarget; 2016 Apr; 7(14):18469-84. PubMed ID: 26943043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MTA1 drives malignant progression and bone metastasis in prostate cancer.
    Kumar A; Dhar S; Campanelli G; Butt NA; Schallheim JM; Gomez CR; Levenson AS
    Mol Oncol; 2018 Sep; 12(9):1596-1607. PubMed ID: 30027683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol regulates PTEN/Akt pathway through inhibition of MTA1/HDAC unit of the NuRD complex in prostate cancer.
    Dhar S; Kumar A; Li K; Tzivion G; Levenson AS
    Biochim Biophys Acta; 2015 Feb; 1853(2):265-75. PubMed ID: 25447541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting MTA1/HIF-1α signaling by pterostilbene in combination with histone deacetylase inhibitor attenuates prostate cancer progression.
    Butt NA; Kumar A; Dhar S; Rimando AM; Akhtar I; Hancock JC; Lage JM; Pound CR; Lewin JR; Gomez CR; Levenson AS
    Cancer Med; 2017 Nov; 6(11):2673-2685. PubMed ID: 29024573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pterostilbene acts through metastasis-associated protein 1 to inhibit tumor growth, progression and metastasis in prostate cancer.
    Li K; Dias SJ; Rimando AM; Dhar S; Mizuno CS; Penman AD; Lewin JR; Levenson AS
    PLoS One; 2013; 8(3):e57542. PubMed ID: 23469203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications.
    Toh Y; Nicolson GL
    Clin Exp Metastasis; 2009; 26(3):215-27. PubMed ID: 19116762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting prostate cancer angiogenesis through metastasis-associated protein 1 (MTA1).
    Kai L; Wang J; Ivanovic M; Chung YT; Laskin WB; Schulze-Hoepfner F; Mirochnik Y; Satcher RL; Levenson AS
    Prostate; 2011 Feb; 71(3):268-80. PubMed ID: 20717904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase D1 regulates subcellular localisation and metastatic function of metastasis-associated protein 1.
    Ganju A; Chauhan SC; Hafeez BB; Doxtater K; Tripathi MK; Zafar N; Yallapu MM; Kumar R; Jaggi M
    Br J Cancer; 2018 Feb; 118(4):587-599. PubMed ID: 29465084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcellular localization of MTA proteins in normal and cancer cells.
    Liu J; Wang H; Huang C; Qian H
    Cancer Metastasis Rev; 2014 Dec; 33(4):843-56. PubMed ID: 25398252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastasis-Associated 1 (MTA1) Gene Expression Promotes Angiogenesis in Mouse Xenografts from Human Non-Small Cell Lung Cancer (NSCLC) Cells.
    Wang T; Li W; Huang H; Wang C
    Med Sci Monit; 2019 Jan; 25():484-491. PubMed ID: 30651530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of MTA proteins in human cancer.
    Kaur E; Gupta S; Dutt S
    Cancer Metastasis Rev; 2014 Dec; 33(4):1017-24. PubMed ID: 25374266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties and clinical relevance of MTA1 protein in human cancer.
    Toh Y; Nicolson GL
    Cancer Metastasis Rev; 2014 Dec; 33(4):891-900. PubMed ID: 25359582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of MTA1 in cancer progression and metastasis.
    Sen N; Gui B; Kumar R
    Cancer Metastasis Rev; 2014 Dec; 33(4):879-89. PubMed ID: 25344802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex.
    Kai L; Samuel SK; Levenson AS
    Int J Cancer; 2010 Apr; 126(7):1538-48. PubMed ID: 19810103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic potential of resveratrol and analogs in preclinical models of prostate cancer.
    Kumar A; Dhar S; Rimando AM; Lage JM; Lewin JR; Zhang X; Levenson AS
    Ann N Y Acad Sci; 2015 Aug; 1348(1):1-9. PubMed ID: 26214308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YB-1 and MTA1 protein levels and not DNA or mRNA alterations predict for prostate cancer recurrence.
    Sheridan CM; Grogan TR; Nguyen HG; Galet C; Rettig MB; Hsieh AC; Ruggero D
    Oncotarget; 2015 Apr; 6(10):7470-80. PubMed ID: 25797255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MTA1-activated Epi-microRNA-22 regulates E-cadherin and prostate cancer invasiveness.
    Dhar S; Kumar A; Gomez CR; Akhtar I; Hancock JC; Lage JM; Pound CR; Levenson AS
    FEBS Lett; 2017 Mar; 591(6):924-933. PubMed ID: 28231399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MTA1 expression in human cancers - Clinical and pharmacological significance.
    Malisetty VL; Penugurti V; Panta P; Chitta SK; Manavathi B
    Biomed Pharmacother; 2017 Nov; 95():956-964. PubMed ID: 28915537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastasis-associated protein 1-mediated antitumor and anticancer activity of dietary stilbenes for prostate cancer chemoprevention and therapy.
    Levenson AS
    Semin Cancer Biol; 2022 May; 80():107-117. PubMed ID: 32126261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.